I am a
Home I AM A Search Login

Papers of the Week

2022 Nov 24

Paediatr Anaesth

Perioperative Intravenous Lidocaine Use in Children.


Heath C, Hii J, Thalayasingam P, von Ungern-Sternberg BS, Sommerfield D
Paediatr Anaesth. 2022 Nov 24.
PMID: 36424875.


Perioperative pain management impacts patient morbidity, quality of life and hospitalization cost. In children, it impacts not only the child, but the whole family. Adjuncts for improved perioperative analgesia continue to be sought to minimize adverse side effects associated with opioids and for those in whom regional or neuraxial anesthesia is not suitable. The use of ketamine and alpha agonists may be useful in these settings but have noted adverse effects including hallucinations, hemodynamic instability and excessive sedation. One alternative is intravenous lidocaine. Despite its off-label use, intravenous lidocaine has demonstrated anti-neuropathic, anti-hyperalgesic and anti-inflammatory actions and is an emerging technique Multiple studies in adults have demonstrated beneficial effects of perioperative intravenous lidocaine including improved perioperative analgesia with reduced postoperative opioid use, improved gastrointestinal function, earlier mobilization, and reduction in hospital length of stay. Despite the limited pediatric literature, some of these findings have been replicated. Larger scale trials providing evidence for pediatric pharmacokinetics and high quality safety data with respect to intravenous lidocaine are still however lacking. To date, dose ranges studied in the pediatric population have not been associated with serious side effects and current data suggests perioperative intravenous lidocaine in a subgroup of pediatric surgical patients seems well tolerated and beneficial.